<DOC>
	<DOCNO>NCT01247584</DOCNO>
	<brief_summary>RATIONALE : Studying bone marrow sample patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study study biomarkers sample young patient acute myeloid leukemia .</brief_summary>
	<brief_title>Biomarkers Samples From Young Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To compare frequency germline telomerase mutation pediatric patient acute myeloid leukemia ( AML ) demonstrate prolonged myelosuppression , define ≥ 1 episode &gt; 35 day neutrophil count recovery chemotherapy , pediatric patient expect myelosuppression , define consistently &lt; 35 day neutrophil count recovery chemotherapy . - To assess association telomerase mutation incidence grade 3 4 mucositis , relapse , death . - To compare germline ( remission ) telomere length pediatric AML patient demonstrate delayed bone marrow recovery pediatric patient consistently expect recovery . - To assess whether correlation telomere length incidence grade 3 4 mucositis , relapse , death exist . OUTLINE : This multicenter study . Cryopreserved bone marrow sample analyze DNA sequence mutation Sanger-based sequencing method , quantitative PCR , SeqMan Pro ( Lasergene DNAStar ) . Results compare previously publish data exist database determine allele frequency control population .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia Enrolled CCG2961 meet 1 follow criterion : More 35 day recover ANC &gt; 500/mm³ course chemotherapy Consistently recover &lt; 35 day ANC &gt; 500/mm³ course chemotherapy Available cryopreserved cell diagnostic endoftherapy sample PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
	<keyword>childhood acute erythroleukemia ( M6 )</keyword>
	<keyword>childhood acute megakaryocytic leukemia ( M7 )</keyword>
	<keyword>childhood acute monoblastic leukemia ( M5a )</keyword>
	<keyword>childhood acute monocytic leukemia ( M5b )</keyword>
	<keyword>childhood acute myeloblastic leukemia without maturation ( M1 )</keyword>
	<keyword>childhood acute myelomonocytic leukemia ( M4 )</keyword>
	<keyword>childhood acute myeloblastic leukemia maturation ( M2 )</keyword>
</DOC>